Stifel Maintains Buy on Guardant Health, Raises Price Target to $180
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Stifel analyst Daniel Arias maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $130 to $180.
Stifel analyst Daniel Arias maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $130 to $180.